🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the efficacy, safety and tolerabili...
Status
Terminated
Location
University of Connecticut Health Center
Start Date
2017-07-18
Trial ID
NCT03234465
This is a randomized, multicenter, phase III trial comparing induction chem...
Status
Terminated
Location
Hôpital de la Pitié-Salpétrière
Start Date
2009-01
Trial ID
NCT00828386
Treatments Being Tested
This is a phase 1 study of the drug dacomitinib with radiotherapy, with or ...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2013-01
Trial ID
NCT01737008
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of linsitinib ...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2011-12
Trial ID
NCT01465815
The purpose of this study is to compare induction chemotherapy (gemcitabine...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2013-11
Trial ID
NCT01872962
Treatments Being Tested
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation t...
Status
Completed
Location
University of Miami
Start Date
2012-01
Trial ID
NCT01485731
The purpose of this study is to determine if Transcranial Direct Current St...
Status
Completed
Location
University of Michigan
Start Date
2014-11
Trial ID
NCT02366611
Treatments Being Tested
This randomized phase II/III trial studies how well pazopanib, when combine...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2014-08-12
Trial ID
NCT02180867
The study is a multicenter, open-label, randomized controlled clinical stud...
Status
Active Not Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2021-07-20
Trial ID
NCT04928807
Treatments Being Tested
This phase I trial studies how well atezolizumab before and/or with standar...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-01-07
Trial ID
NCT03738228
Treatments Being Tested